Cell cycle regulation by the Wee1 Inhibitor PD0166285, Pyrido 2,3-d pyimidine, in the B16 mouse melanoma cell lineReportar como inadecuado




Cell cycle regulation by the Wee1 Inhibitor PD0166285, Pyrido 2,3-d pyimidine, in the B16 mouse melanoma cell line - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

BMC Cancer

, 6:292

First Online: 19 December 2006Received: 13 July 2006Accepted: 19 December 2006DOI: 10.1186-1471-2407-6-292

Cite this article as: Hashimoto, O., Shinkawa, M., Torimura, T. et al. BMC Cancer 2006 6: 292. doi:10.1186-1471-2407-6-292

Abstract

BackgroundWee1 kinase plays a critical role in maintaining G2 arrest through its inhibitory phosphorylation of cdc2. In previous reports, a pyridopyrimidine molecule PD0166285 was identified to inhibit Wee1 activity at nanomolar concentrations. This G2 checkpoint abrogation by PD0166285 was demonstrated to kill cancer cells, there at a toxic highest dose of 0.5 μM in some cell lines for exposure periods of no longer than 6 hours. The deregulated cell cycle progression may have ultimately damaged the cancer cells. We herein report one of the mechanism by which PD0166285 leads to cell death in the B16 mouse melanoma cell line.

MethodsTumor cell proliferation was determined by counting cell numbers. Cell cycle distribution was determined by flow cytometry. Morphogenesis analysis such as microtubule stabilization, Wee1 distribution, and cyclin B location were observed by immunofluorescence confocal microscopy. An immunoblot analysis of cdc2-Tyr15, cyclin D, E, p16, 21, 27, and Rb. A real-time PCR of the mRNA of cyclin D were completed.

ResultsIn our experiment, B16 cells also dramatically abrogated the G2 checkpoint and were found to arrest in the early G1 phase by treatment with 0.5 μM for 4 hours observed by flow cytometry. Cyclin D mRNA decreased within 4 hours observed by Real-time PCR. Rb was dephosphrylated for 24 hours. However, B16 cells did not undergo cell death after 0.5 μM treatment for 24 hours. Immnofluoscence microscopy showed that the cells become round and small in the morphogenesis. More interesting phenomena were that microtubule stabilization was blocked, and Wee1 distribution was restricted after treatment for 4 hours.

ConclusionWe analyzed the effect of Wee1 inhibitor PD0166285 described first by Wang in the G2 transition in the B16 melanoma cell line. The inhibitor PD0166285 abrogated G2-M checkpoint inducing early cell division. Moreover, we found that the treatment of cells with the inhibitor is related to microtubule stabilization and decrease in cyclin D transcription. These effects together suggest that Wee1 inhibitor may thus be a potentially useful anti-cancer therapy.

Electronic supplementary materialThe online version of this article doi:10.1186-1471-2407-6-292 contains supplementary material, which is available to authorized users.

Download fulltext PDF



Autor: Osamu Hashimoto - Masako Shinkawa - Takuji Torimura - Toru Nakamura - Karuppaiyah Selvendiran - Masaharu Sakamoto - Hironori

Fuente: https://link.springer.com/







Documentos relacionados